Current status and future perspectives of fecal immunological markers in the differential diagnosis of Clostridioides difficile infection in children
Authors:
Open Access
- 21 February 2026
- journal article
- review article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 45 (5) , 1237-1245
Abstract
Objective The rising incidence of pediatric Clostridioides difficile infection (CDI) and its nonspecific clinical presentation pose a significant diagnostic challenge. Current methods (e.g., NAATs, toxin tests) fail to distinguish active infection from asymptomatic colonization reliably. This review assesses the potential of fecal immunological markers to improve the differential diagnosis of pediatric CDI. Methods We synthesized current literature on the epidemiology and diagnostic challenges of pediatric CDI, the limitations of existing diagnostic strategies, and the evidence for fecal immunological markers—including inflammatory mediators, antimicrobial peptides, and immunoglobulins—in distinguishing CDI from non-CDI diarrhea. Results Fecal immunological markers, such as IL-8, IL-1β, calprotectin, and human defensin-5, reflect intestinal mucosal inflammation and the host response during CDI. Elevated IL-8 and IL-1β are associated with disease severity, while fecal calprotectin > 500 µg/g shows high specificity for CDI and predicts recurrence risk. Dynamic changes in sIgA correlate with mucosal immunity and relapse. CDI exhibits a distinct “hyper-inflammatory” profile dominated by IL-1β/IL-8, contrasting with the Th1/interferon-driven response typical of viral diarrhea. However, variability in assay methods, lack of pediatric reference thresholds, and insufficient validation in diverse cohorts limit current clinical applicability. Conclusions Fecal immunological markers represent a promising shift toward a host-focused diagnostic approach for pediatric CDI. Future efforts should prioritize standardized assays, multi-marker panels, and well-designed prospective studies in children to validate their role in guiding diagnosis and personalized management.Keywords
Funding Information
- Shanghai Shengkang Hospital Development Center Technical Standardization Management and Promotion Project (SHDC22024253)
- National Natural Science Foundation of China (82470572)
This publication has 49 references indexed in Scilit:
- Isothermal Nucleic Acid Amplification Technologies and CRISPR‐Cas‐Based Nucleic Acid Detection Strategies for Infectious Diseases Diagnostics2025
- Implementing a multiplex-PCR test for the diagnosis of acute gastroenteritis in hospitalized children: Are all enteric viruses the same?Journal of Clinical Virology, 2023
- History of global food safety, foodborne illness, and risk assessment2023
- Diarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and ManagementClinical Gastroenterology and Hepatology, 2020
- Elevated serum CXCL10 in patients with Clostridium difficile infection are associated with disease severityInternational Immunopharmacology, 2019
- Toxigenic Clostridium difficile carriage in general practice: results of a laboratory-based cohort studyClinical Microbiology and Infection, 2019
- How to: diagnose infection caused by Clostridium difficileClinical Microbiology and Infection, 2018
- Rapid detection of Clostridium difficile toxins and laboratory diagnosis of Clostridium difficile infectionsInfection, 2016
- European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infectionClinical Microbiology and Infection, 2016
- The role of glutamate dehydrogenase for the detection of Clostridium difficile in faecal samples: a meta-analysisJournal of Hospital Infection, 2011